Government jobs • Exam updates • PreparationIndependent information portal
RojgarRankYOUR NEXT STEP STARTS HERE
Current Affairs

India Proposes Amendments to Medical Devices Rules, 2026

By Published

On 28 June 2026, India’s Ministry of Health and Family Welfare proposed amendments to the Medical Devices Rules, 2017, aimed at streamlining licensing timelines and enhancing regulatory controls for medical devices. Key changes include reducing manufacturing licence approval durations, introducing sterilisation labelling requirements, updating government fees, and implementing a digital filing system. Medical devices in India are classified into risk-based categories (Class A to D), which guide regulatory control and oversight.

On this page

Key Facts

  • Proposed on 28 June 2026 by India’s Ministry of Health and Family Welfare.
  • Amends Medical Devices Rules, 2017, governing manufacture, import, sale, and distribution of medical devices in India.
  • Reduces manufacturing licence timelines: Class B devices (low-to-moderate risk) from 140 to 115 days; Class C and D devices (high risk) from 105 to 90 days.
  • Introduces sterilisation labelling requirements on medical devices to enhance traceability and patient safety.
  • Includes stricter compliance monitoring and updated government fees.
  • Implements a digital filing system for license applications and compliance documentation.
  • India’s medical device classification system includes Classes A, B, C, and D based on risk levels for regulatory purposes.

Background & Context

The Medical Devices Rules, 2017, are the primary regulatory framework in India for medical devices, covering licensing, import, manufacture, sale, and distribution. Devices are classified into risk-based categories (A to D) to align regulatory controls with potential risk to patients and users. The 2026 amendments respond to the need for greater regulatory clarity, faster approval processes, and enhanced patient safety measures in line with global medical device regulatory trends.

Why This Matters for Exams / Exam Relevance

These amendments constitute significant regulatory reforms in Indian health law and medical device governance, crucial for exams related to health policy, public administration, and law. Candidates should understand the revised licensing timelines, the classification system for medical devices, and new safety measures such as sterilisation labelling. These changes exemplify India's steps to modernize its regulatory system and improve access to safe medical technologies.

Points to Remember

  • The Medical Devices Rules, 2017, were amended in 2026 by the Ministry of Health and Family Welfare.
  • Licence approval durations reduced for Class B devices from 140 to 115 days; for Class C and D devices from 105 to 90 days.
  • New sterilisation labelling requirements introduced to strengthen traceability.
  • Digital filing system and updated government fees have been implemented to streamline processes.
  • Indian medical devices classified into Classes A (lowest risk) through D (highest risk), guiding regulatory oversight.
← Back to Current Affairs